GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY...

Hematological Oncology 2017 / 06 Vol. 35

GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS

Schuster, S.J., Bishop, M.R., Tam, C., Waller, E.K., Borchmann, P., Mcguirk, J., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J., Fleury, I., Bachanova, V., Foley, S.R., Ho, P.J., Mielke, S., Holt
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_6
Date:
June, 2017
File:
PDF, 68 KB
english, 2017
Conversion to is in progress
Conversion to is failed